Contrarily, antibody-mediated inhibition of VEGF in prostate cancer led to complete suppression of angiogenesis and prevents tumour growth beyond the initial prevascular growth phase (Borgstrom et al, 1998). This evidence concerns the gene VEGFA and neoplasm.